CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir

David Sooik Kim, Mi Young Jeon, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim

Clin Mol Hepatol. 2019;25(3):283-293. Published online 2018 November 13 DOI: https://doi.org/10.3350/cmh.2018.0054

Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir

David Sooik Kim, Mi Young Jeon, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim

Clinical and Molecular Hepatology. 2019;25(3):283-293

Link1

Link2 Link3

Tu1029 Hepatic Steatosis is a Causative Factor for Entecavir Treatment Failure in Chinese Patients With Chronic Hepatitis B

Xi Jin

Gastroenterology. 2012;142(5):S-1015

Link1 Link2

Concentration of LDLR, degree of hepatic fibrosis and hepatic steatosis in patients with chronic hepatitis B infection treated with tenofovir disoproxil fumarate

Agnieszka Pokora - Rodak, Joanna Krzowska-Firych, Krzysztof Tomasiewicz

Annals of Agricultural and Environmental Medicine. 2021;28(3):458-462

Link1 Link2

Exam 2: Similar Risk of Renal Events Among Patients Treated With Tenofovir or Entecavir for Chronic Hepatitis B

Clinical Gastroenterology and Hepatology. 2012;10(8):e68

Link1 Link2

Response to tenofovir monotherapy in chronic hepatitis B patients with prior suboptimal response to entecavir

C. Q. Pan, K.-Q. Hu, A. S. Yu, W. Chen, C. Bunchorntavakul, K. R. Reddy

Journal of Viral Hepatitis. 2011;19(3):213-219

Link1 Link2

Comparable outcomes of decompensated chronic hepatitis B patients treated with entecavir or tenofovir: an 8-year cohort study

Kuan-Chieh Lee, Jur-Shan Cheng, Ming-Ling Chang, Rong-Nan Chien, Yun-Fan Liaw

Hepatology International. 2022;16(4):799-806

Link1

Link2 Link3

Renal outcomes in chronic hepatitis b patients treated with tenofovir disoproxil fumarate or entecavir: a propensity score matched study

S. Trinh, A. Le, J. Hoang, D. Jeong, M. Chung, M.-H. Lee, U. Wang, M. Nguyen

Journal of Hepatology. 2018;68:S519-S520

Link1 Link2

250 - Renal Outcomes in Chronic Hepatitis B Patients Treated with Tenofovir Disoproxil Fumarate or Entecavir: A Propensity Score Matched Study

Sam Trinh, An K. Le, Joseph Hoang, Donghak Jeong, Mimi Chung, Mei-Hsuan Lee, Uerica Wang, Mindie H. Nguyen

Gastroenterology. 2018;154(6):S-1081

Link1 Link2

Low-level viremia in patients with chronic hepatitis B receiving entecavir, tenofovir and tenofovir alafenamide

Xiaohao Wang, Dachuan Cai, Zhang Juan

Journal of Hepatology. 2022;77:S878

Link1 Link2

Mortality, liver transplantation and hepatic complications in patients with treatment‐naïve chronic hepatitis B treated with entecavir vs tenofovir

Byung Gyu Kim, Neung Hwa Park, Seung Bum Lee, Hojune Lee, Byung Uk Lee, Jae Ho Park, Seok Won Jung, In Du Jeong, Sung‐Jo Bang, Jung Woo Shin

Journal of Viral Hepatitis. 2018;25(12):1565-1575

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.